152 related articles for article (PubMed ID: 31734783)
21. Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.
Zykova TA; Zhu F; Lu C; Higgins L; Tatsumi Y; Abe Y; Bode AM; Dong Z
Clin Cancer Res; 2006 Dec; 12(23):6884-93. PubMed ID: 17145805
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon.
Xiao J; Duan Q; Wang Z; Yan W; Sun H; Xue P; Fan X; Zeng X; Chen J; Shao C; Zhu F
Oncotarget; 2016 Apr; 7(17):24483-94. PubMed ID: 27016416
[TBL] [Abstract][Full Text] [Related]
23. TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.
Li Y; Yang Z; Li W; Xu S; Wang T; Wang T; Niu M; Zhang S; Jia L; Li S
Oncotarget; 2016 Feb; 7(6):6748-64. PubMed ID: 26745678
[TBL] [Abstract][Full Text] [Related]
24. TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation.
Uchida E; Suwa S; Yoshimoto R; Watanabe K; Kasama T; Miura O; Fukuda T
Int J Oncol; 2019 May; 54(5):1785-1796. PubMed ID: 30864683
[TBL] [Abstract][Full Text] [Related]
25. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
[TBL] [Abstract][Full Text] [Related]
26. [Cyanidin-3-O-glucoside inhibits proliferation of colorectal cancer cells by targeting TOPK].
Wang L; Liu F; Liu Y; Gao H; Dong M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1101-1108. PubMed ID: 31894009
[TBL] [Abstract][Full Text] [Related]
27. Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase.
Xue P; Wang Y; Zeng F; Xiu R; Chen J; Guo J; Yuan P; Liu L; Xiao J; Lu H; Wu D; Pan H; Lu M; Zhu F; Shi F; Duan Q
Oncotarget; 2017 Apr; 8(16):27093-27104. PubMed ID: 28404919
[TBL] [Abstract][Full Text] [Related]
28. TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis.
Matsuo Y; Park JH; Miyamoto T; Yamamoto S; Hisada S; Alachkar H; Nakamura Y
Sci Transl Med; 2014 Oct; 6(259):259ra145. PubMed ID: 25338756
[TBL] [Abstract][Full Text] [Related]
29. T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.
Herbert KJ; Ashton TM; Prevo R; Pirovano G; Higgins GS
Cell Death Dis; 2018 Oct; 9(11):1089. PubMed ID: 30356039
[TBL] [Abstract][Full Text] [Related]
30. Cefradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of T-LAK cell-originated protein kinase.
Fan X; Duan Q; Ke C; Zhang G; Xiao J; Wu D; Zeng X; Chen J; Guo J; Zhou J; Shi F; Zhu F
Oncotarget; 2016 Apr; 7(17):24633-45. PubMed ID: 27016423
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032.
Eedara BB; Manivannan B; Alabsi W; Sun B; Curiel-Lewandrowski C; Zhang T; Bode AM; Mansour HM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958502
[TBL] [Abstract][Full Text] [Related]
32. 3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase
Fu X; Zhao R; Yoon G; Shim JH; Choi BY; Yin F; Xu B; Laster KV; Liu K; Dong Z; Lee MH
Front Cell Dev Biol; 2021; 9():638174. PubMed ID: 33842463
[TBL] [Abstract][Full Text] [Related]
33. PDZ-binding kinase/T-LAK cell-originated protein kinase is a target of the fucoidan from brown alga Fucus evanescens in the prevention of EGF-induced neoplastic cell transformation and colon cancer growth.
Vishchuk OS; Sun H; Wang Z; Ermakova SP; Xiao J; Lu T; Xue P; Zvyagintseva TN; Xiong H; Shao C; Yan W; Duan Q; Zhu F
Oncotarget; 2016 Apr; 7(14):18763-73. PubMed ID: 26936995
[TBL] [Abstract][Full Text] [Related]
34. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells.
Abe Y; Matsumoto S; Kito K; Ueda N
J Biol Chem; 2000 Jul; 275(28):21525-31. PubMed ID: 10781613
[TBL] [Abstract][Full Text] [Related]
35. TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer.
Sun H; Zhang L; Shi C; Hu P; Yan W; Wang Z; Duan Q; Lu F; Qin L; Lu T; Xiao J; Wang Y; Zhu F; Shao C
Oncotarget; 2015 May; 6(14):12392-404. PubMed ID: 25881543
[TBL] [Abstract][Full Text] [Related]
36. PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.
Huang H; Lee MH; Liu K; Dong Z; Ryoo Z; Kim MO
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066486
[TBL] [Abstract][Full Text] [Related]
37. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
[TBL] [Abstract][Full Text] [Related]
38. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase.
Dougherty JD; Garcia AD; Nakano I; Livingstone M; Norris B; Polakiewicz R; Wexler EM; Sofroniew MV; Kornblum HI; Geschwind DH
J Neurosci; 2005 Nov; 25(46):10773-85. PubMed ID: 16291951
[TBL] [Abstract][Full Text] [Related]
39. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
[TBL] [Abstract][Full Text] [Related]
40. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
Oh SM; Zhu F; Cho YY; Lee KW; Kang BS; Kim HG; Zykova T; Bode AM; Dong Z
Cancer Res; 2007 Jun; 67(11):5186-94. PubMed ID: 17545598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
